rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Exicure, Inc.

XCUR · Nasdaq

Health CareBiotechnologyNot moving yet

XCUR stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 53.2% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$19.4M
Officials’ trades on record
0
Institutions holding
16 (+0)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$14.7M$0$7.8MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months4
Buyers · sellers0 · 2
WhoDidSharesTraded
Exicure Hitron Inc.10% ownersold258,367at $4.5021 Jan 2026filed 21 Jan 2026
Exicure Hitron Inc.10% ownersold734,747at $4.5016 Jan 2026filed 20 Jan 2026
Exicure Hitron Inc.10% ownersold741,272at $4.507 Jan 2026filed 8 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders16+0 on the quarter
New · exited3 · 3
Reported value$284K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 202643,111$90K+10,128+30.7%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 202631,249$65K-5,664−15.3%
JANE STREET GROUP, LLCnew · filed 14 Aug 202629,535$61K+29,535
CITADEL ADVISORS LLCnew · filed 14 Aug 202614,919$31K+14,919
VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 202613,161$27K00.0%
Tower Research Capital LLC (TRC)added · filed 11 Aug 20264,074$8,474+3,585+733.1%
UBS Group AGreduced · filed 13 Aug 2026342$711-524−60.5%
MORGAN STANLEYreduced · filed 13 Aug 2026143$297-15−9.5%
SBI Securities Co., Ltd.unchanged · filed 23 Jul 202643$8900.0%
BlackRock, Inc.reduced · filed 7 Aug 202635$73-9,318−99.6%
30 Sep 2024 – 30 Jun 2026
101316Sep 24Mar 25Sep 25Dec 25Jun 26

News

No headline names it lately.

Everyone who traded it

Exicure HiTron Inc. Company insider10% owner · last 8 Jul 20261 · 3
Josh Miller Company insiderChief Accounting Officer · last 16 Feb 20260 · 0
Sangsangin Investment & Securities Co., Ltd. Company insider10% owner · last 8 Dec 20250 · 1
Dgp Co., Ltd. Company insider10% owner · last 12 Sep 20241 · 1
Cbi Usa, Inc. Company insider10% owner · last 23 Jun 20231 · 0
Jiyoung Hwang Company insiderDirector · last 4 Jan 20230 · 0
Bali Muralidhar Company insiderDirector · last 13 Jun 20222 · 0
Elizabeth A. Garofalo Company insiderDirector · last 13 Jun 20220 · 0
James R. Sulat Company insiderDirector · last 13 Jun 20220 · 0
Jeffrey L. Cleland Company insiderDirector · last 13 Jun 20220 · 0
Elias D. Papadimas Company insiderChief Financial Officer · last 16 May 20221 · 0
Matthias Schroff Company insiderChief Executive Officer · last 16 May 20220 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-41.7%
Share count trendFY 2025 · to 17 Mar 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$3.7M
Free cash flowFY 2025 · to 31 Dec 2025−$8.6M

Analyst forecasts

No analyst forecasts yet.